Search company, investor...

Founded Year



Unattributed | Alive

Total Raised


About ABCDx

ABCDx develops a portfolio of diagnostic tools for brain diseases to detect patients with mild traumatic brain injuries (TBI). It offers a blood-based biomarker test to rule in and rule out a mild traumatic brain injury. It delivers its products to healthcare professionals, sports, and military organizations. The company was founded in 2014 and is based in Geneva, Switzerland.

Headquarters Location

Avenue de Sécheron 15 29, quai du Mont-Blanc

Geneva, 1202,


+41 22 545 12 89


ABCDx's Products & Differentiators


    The first mobile, clinically validated, Software as a Medical Device brain diagnostics ecosystem


Latest ABCDx News

The first kicks of 2018!

Apr 26, 2023

15.01.2018 Congratulations to the first four winners of the CHF 10,000 prize for 2018: RiskTalk, ABCDx, REM Analytics and UniSieve in fields as diverse as in-vitro diagnostics (Medtech), microtype profiling (Biotech), anonymous reporting systems (Software) and cleaning up petrochemical separation (Cleantech). Jean-Charles Sanchez from ABCDx Charlie Newman from RiskTalk ABCDx (University of Geneva) Medtech ABCDx provides powerful new in vitro diagnostics (IVD) tools for transforming the triage, diagnosis and treatment decision process at the point of care for patients presenting with potential brain injury, ranging from stroke and trauma to complications.By developing a tool that searches for certain biomarkers (chemical reactions in the brain), this enables a clinician to understand what is happening within a patient and thus administer the correct treatment quickly, reducing the risk of long term damage. REM Analytics, (EPFL) Biotech The human microbiome is the complex ecology of bacteria living around and inside us, mostly in the gut. Every individual has a specific microbiome: their “microtype,” which is susceptible to modifications and imbalances. REM Analytics, proposes new technique to accurately profile the microtype of individuals. As a research service to probiotic companies, they will provide accurate measurement of the specific effect a probiotic is having on its consumers. This will allow the probiotic industry to better demonstrate the therapeutic purpose of their products, thereby boosting their sales and increasing their margins. They will use their measurements to develop the worlds first large, high quality microbiome data, with the potential to change the way in which we view health, nutrition and treatment. RiskTalk (UNIL/HEC) Enterprise Software, SaaS, IT, Risk Management RiskTalk empowers any employee to report anything, directly to their organisation's leadership, completely anonymously, via a simple app. In a ‘back office’, risk controllers will see issues flagged and sorted by organizational priorities – which then directs attention and follow-up action, with the back office team remaining in contact with the reporter. The reporter’s identity remains a secret, particularly when the software strips out identifying data from any supporting files that may be submitted. UniSieve (ETH Zurich) Cleantech, Petrochemical Industry Over 10% of total energy consumption worldwide is due to separation processes. To target this issue, UniSieve has developed a patent-pending membrane technology, which allows cost-and energy-efficient separation of gases. The technology is based on an inventive way of integrating metal-organic frameworks (MOFs) into polymeric membranes. The UniSieve technology has the potential to create various separation solutions for small-scale home applications (B2C), and also large-scale industrial processes (B2B). Currently, the focus is set on building modules for the purification of hydrogen (energy, cleantech industry) and propylene (oil&gas, chemical industry). Additional Links

ABCDx Frequently Asked Questions (FAQ)

  • When was ABCDx founded?

    ABCDx was founded in 2014.

  • Where is ABCDx's headquarters?

    ABCDx's headquarters is located at Avenue de Sécheron 15, Geneva.

  • What is ABCDx's latest funding round?

    ABCDx's latest funding round is Unattributed.

  • How much did ABCDx raise?

    ABCDx raised a total of $3.79M.

  • Who are the investors of ABCDx?

    Investors of ABCDx include EIC Accelerator, Fongit Seed Invest, Eurostars Programme and Venture Kick.

  • What products does ABCDx offer?

    ABCDx's products include BrainCheck.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.